Innovation

9 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 58 times.

Year	Filings
2013	1

Investor mix

8 investors on record; lead investors include Forward Ventures, Boston Millennia Partners; 1 has since exited.

Investor type	Count	Share
Venture capital	5	63%
Private equity	1	13%
Other / undisclosed	2	25%